MANIFESTATIONS OF THE FUNCTIONAL-HETEROGENEITY OF PEPTIDOGLYCANS IN OPSONOPHAGOCYTIC REACTIONS

被引:0
作者
MAYANSKY, AN
SIBIRYAKOVA, NI
ASTAFYEV, DG
FOKINA, YV
机构
来源
ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII | 1993年 / 02期
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The peptidoglycan activity of Staphylococcus aureus CCM 885 and Bifidobacterium bifidum 1 was studied in the opsonophagocytic system on the basis of the luminol-dependent chemiluminescence of human neutrophils. B. bifidum peptidoglycan was more active in direct interaction with neutrophils. After treatment with normal human serum S. aureus peptidoglycan showed more pronounced neutrophil-stimulating properties. This phenomenon was in accord with a higher content of IgG antibodies to S. aureus peptidoglycan, as well as with its capacity for the classical direct activation of the complement. Moreover, in reactions' with S. aureus peptidoglycan ''minor'' opsonins, independent of antibodies and complement, were detected. B. bifidum peptidoglycan did not activate the complement, could not be opsonized with the serum having no specific antibodies and did not react with ''minor'' opsonins.
引用
收藏
页码:114 / 118
页数:5
相关论文
共 15 条
[1]  
ASTAFEV DG, 1987, THESIS CHELYABINSK
[2]  
ASTAFYEV DG, 1986, ZH MIKROB EPID IMMUN, P48
[3]  
AZOV NA, 1985, ZH MIKROB EPID IMMUN, P66
[4]  
DSIARSKI R, 1976, ZBL BAKT 1, P393
[5]   ACTIVATION OF ALTERNATE COMPLEMENT PATHWAY BY PEPTIDOGLYCAN FROM STREPTOCOCCAL CELL-WALL [J].
GREENBLATT, J ;
BOACKLE, RJ ;
SCHWAB, JH .
INFECTION AND IMMUNITY, 1978, 19 (01) :296-303
[6]  
HIRSCH JG, 1964, J IMMUNOL, V92, P155
[7]  
LEBEDEVA YV, 1989, MODELIROVANIE KLINIC, P64
[8]  
NEVMYATULLIN AL, 1985, ZH MIKROB EPID IMMUN, P67
[9]   COMPLEMENT CONSUMPTION BY GONOCOCCAL PEPTIDOGLYCAN [J].
PETERSEN, BH ;
ROSENTHAL, RS .
INFECTION AND IMMUNITY, 1982, 35 (02) :442-448
[10]   KEY ROLE OF PEPTIDOGLYCAN IN OPSONIZATION OF STAPHYLOCOCCUS-AUREUS [J].
PETERSON, PK ;
WILKINSON, BJ ;
KIM, Y ;
SCHMELING, D ;
DOUGLAS, SD ;
QUIE, PG ;
VERHOEF, J .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (03) :597-609